ReviewClinical and translational medicine2026
Glucose metabolic reprogramming as a driver of immunosuppression in the tumour microenvironment.
Yang Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it